1610359-09-5

Basic information

• Product Name: 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{6-methoxy-4-[(methylsulfanyl)methyl]pyridin-2-yl}pyridin-2-amine
• Synonyms: 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{6-methoxy-4-[(methylsulfanyl)methyl]pyridin-2-yl}pyridin-2-amine
• CAS NO: 1610359-09-5
• Molecular Weight: 403.453
• Mol File: 1610359-09-5.mol

Chemical Properties

• CAS DataBase Reference: 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{6-methoxy-4-[(methylsulfanyl)methyl]pyridin-2-yl}pyridin-2-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{6-methoxy-4-[(methylsulfanyl)methyl]pyridin-2-yl}pyridin-2-amine(1610359-09-5)
• EPA Substance Registry System: 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{6-methoxy-4-[(methylsulfanyl)methyl]pyridin-2-yl}pyridin-2-amine(1610359-09-5)

Safety Data

• Hazardous Substances Data: 1610359-09-5(Hazardous Substances Data)

Upstream product

• 179899-07-1 4-fluoro-2-methoxyphenylboronic acid 
• 884494-49-9 2-chloro-5-fluoro-4-iodopyridine 
• 478946-80-4 4-(bromomethyl)-2-chloro-6-methoxypyridine 
• 1602486-07-6 5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-amine 
• 1610359-08-4 2-chloro-6-methoxy-4-[(methylsulfanyl)methyl]pyridine 
• 1602486-03-2 2-chloro-5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridine 

Downstream Products

• 1610358-65-0 (rac)-5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{6-methoxy-4-[(S-methylsulfonimidoyl)methyl]pyridin-2-yl}pyridin-2-amine 
• 1610359-10-8 2,2,2-trifluoro-N-{[(2-{[5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-yl]amino}-6-methoxypyridin-4-yl)methyl](methyl)-λ⁴-sulfanylidene}acetamide 

Relevant articles and documents

5-FLUORO-N-(PYRIDIN-2-YL)PYRIDIN-2-AMINE DERIVATIVES CONTAINING A SULFOXIMINE GROUP

The present invention relates to 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group of general formula (I) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, in particular of hyper-proliferative disorders and/or virally induced infectious diseases and/or of cardiovascular diseases. The invention further relates to intermediate compounds useful in the preparation of said compounds of general formula (I).